The objective of this study was to determine whether AMPK is activated by 2-arachidonoylglycerol (2-AG) and participates to the cytoskeleton control in human platelets. We found that 2-AG stimulates the AMPKalfa activation through a Ca2+/Calmodulin-dependent pathway as the specific inhibition of the CaMKKbeta by STO-609 inhibits the AMPKalfa phosphorylation/activation. Moreover, the CaMKKbeta/AMPKalfa pathway activated by 2-AG is involved in the phosphorylation of cofilin, vasodilator stimulated phosphoprotein (VASP), and myosin light chain (MLCs). These proteins participate to actin cytoskeletal remodelling during aggregation. We found that the phosphorylation/activation inhibition of these proteins is associated with a significant reduction in actin polymerization, aggregation, ATP, and alfa-granule secretion. Finally, AMPKalfa activation, Cofilin, VASP, and MLCs phosphorylation are significantly reduced by SR141716, the specific inhibitor of type 1 cannabinoid (CB1) receptor, suggesting that the CB1 receptor is involved in the 2-AG effect. In conclusion, we have shown that the CaMKKbeta/AMPKalfa pathway is activated by 2-AG in human platelets and controls the phosphorylation of key proteins involved in actin polymerization and aggregation.

Activation of CaMKKbeta/AMPKalfa pathway by 2-AG in human platelets

SIGNORELLO, MARIA GRAZIA;LEONCINI, GIULIANA
2018-01-01

Abstract

The objective of this study was to determine whether AMPK is activated by 2-arachidonoylglycerol (2-AG) and participates to the cytoskeleton control in human platelets. We found that 2-AG stimulates the AMPKalfa activation through a Ca2+/Calmodulin-dependent pathway as the specific inhibition of the CaMKKbeta by STO-609 inhibits the AMPKalfa phosphorylation/activation. Moreover, the CaMKKbeta/AMPKalfa pathway activated by 2-AG is involved in the phosphorylation of cofilin, vasodilator stimulated phosphoprotein (VASP), and myosin light chain (MLCs). These proteins participate to actin cytoskeletal remodelling during aggregation. We found that the phosphorylation/activation inhibition of these proteins is associated with a significant reduction in actin polymerization, aggregation, ATP, and alfa-granule secretion. Finally, AMPKalfa activation, Cofilin, VASP, and MLCs phosphorylation are significantly reduced by SR141716, the specific inhibitor of type 1 cannabinoid (CB1) receptor, suggesting that the CB1 receptor is involved in the 2-AG effect. In conclusion, we have shown that the CaMKKbeta/AMPKalfa pathway is activated by 2-AG in human platelets and controls the phosphorylation of key proteins involved in actin polymerization and aggregation.
File in questo prodotto:
File Dimensione Formato  
revised manuscript.docx

accesso chiuso

Tipologia: Documento in Pre-print
Dimensione 70.64 kB
Formato Microsoft Word XML
70.64 kB Microsoft Word XML   Visualizza/Apri   Richiedi una copia
figures.ppt

accesso chiuso

Tipologia: Documento in Pre-print
Dimensione 843 kB
Formato Microsoft Powerpoint
843 kB Microsoft Powerpoint   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/875849
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact